Healthpoint, a part of the health company M42 group, has launched the Vein Clinic and Diabetic Foot and Limb Preservation Programme, to provide specialised care for patients with diabetes-related foot complications, according to a press release posted on Zawya.
This initiative comes in response to the high prevalence of diabetic foot ulcers (DFUs) in the Middle East and North Africa (MENA) region, as reported by the International Diabetes Foundation (IDF).
The programme adopts a comprehensive, multidisciplinary approach to manage the serious risks posed by diabetes, including severe foot issues, ulcers, and potential amputations.
Healthpoint's strategy includes continuous monitoring, preventive care, and specialised footwear to reduce these risks.
The network of specialists at Healthpoint in vascular surgery, podiatry, orthotics, orthopaedics, and wound care collaborate to offer integrated, one-stop care for patients.
In addition to the preservation programme, Vein Clinic provides a variety of surgical and non-surgical treatments for venous and lymphatic conditions.
Advanced thermal ablation techniques such as laser and radiofrequency ablation for varicose veins, non-thermal options such as glue and sclerotherapy, and cosmetic phlebology treatments including laser, CLACS, and foam sclerotherapy are available.
The clinic also offers minimally invasive endovascular surgeries and features the innovative high-intensity focused ultrasound (HIFU/Sonovein) treatment, a non-invasive procedure using ultrasound technology for varicose vein treatment.
Healthpoint acting medical director Dr Mohammed Al Hadad said: “These programmes not only enhance our ability to address complex conditions with precision and compassion, but also reflect our commitment to fostering a collaborative approach to patient health.
"We are proud to offer these advanced services and are confident they will make a meaningful difference in our patients’ lives.”
Dr Francesco Serino, an international vascular surgeon with over 37 years pf experience, has been appointed to lead these advancements at Healthpoint.
Dr Serino said: “I am thrilled to be part of Healthpoint and look forward to offering our patients the highest quality of vascular care. Our goal is to provide state-of-the-art treatments and personalised care for patients with venous and diabetic foot conditions.
“By collaborating with international networks, we are committed to achieving the highest standards of practice and optimal patient outcomes.”
